Author

Miguel Pocovı́

Observed names: M POCOVI, M Pocovi, M Pocoví, M. Pocovi, M. Pocovi´, M. Pocoví, M. Pocoví, M. Pocovı́, Miguel POCOVI, Miguel Pocovi, Miguel Pocoví, Miguel Pocoví, Pocovi, Miguel

Observed institutions: Tufts University, Tufts Medical Center, Centre National de la Recherche Scientifique, Universidad de Cantabria, Mayo Clinic, Inserm, University of Utah, Universidad de Zaragoza, Great Ormond Street Hospital, Instituto de Salud Carlos III, Institut de génétique et de biologie moléculaire et cellulaire, ProterixBio (United States), Centro de Investigación en Red en Enfermedades Cardiovasculares, Hospital Universitario 12 De Octubre, Centre for Biomedical Network Research on Rare Diseases, Jean Mayer Human Nutrition Research Center on Aging, Hospital Universitario Miguel Servet, Centro de Investigación Biomédica en Red, Hospital Clínic de Barcelona, Framingham Heart Study, Hospital Universitario Fundación Jiménez Díaz, Hospital Clínico Universitario Lozano Blesa, Instituto de Investigación Sanitaria Aragón, ProThera Biologics (United States), Instituto Aragonés de Ciencias de la Salud, Hospital General San Jorge, Hôpital d'Hautepierre, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Instituto de Biologia Molecular e Celular, Sociedad Española de Arteriosclerosis, Universitat de les Illes Balears, Université de Strasbourg

OpenAlex ID: A5111762332

Femoral and Carotid Subclinical Atherosclerosis Association With Risk Factors and Coronary Calcium

2016 · Martín Laclaustra, José A. Casasnovas, et al. · Journal of the American College of Cardiology · 244

PDF

Association of Polymorphisms at the SR-BI Gene Locus With Plasma Lipid Levels and Body Mass Index in a White Population

1999 · Susan Acton, Doreen Osgood, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 213

Comparison of Genetic Versus Clinical Diagnosis in Familial Hypercholesterolemia

2008 · Fernando Civeira, Emilio Ros, et al. · The American Journal of Cardiology · 180

A Third Major Locus for Autosomal Dominant Hypercholesterolemia Maps to 1p34.1-p32

1999 · Mathilde Varret, Jean-Pierre Rabès, et al. · The American Journal of Human Genetics · 175

Recommendations for the detection and diagnosis of Niemann-Pick disease type C

2017 · Marc C. Patterson, Peter Clayton, et al. · Neurology Clinical Practice · 162

PDF

Higher Incidence of Mild Cognitive Impairment in Familial Hypercholesterolemia

2010 · Daniel Zambón, Melibea Quintana, et al. · The American Journal of Medicine · 148

Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus Relationships with lipids, apolipoproteins, and premature coronary artery disease

1991 · J.M. Ordovas, F. Civeira, et al. · Atherosclerosis · 145

Clinical experience with miglustat therapy in pediatric patients with Niemann–Pick disease type C: A case series

2009 · M. Pineda, M.S. Perez-Poyato, et al. · Molecular Genetics and Metabolism · 139

Pediatric non-neuronopathic Gaucher disease: presentation, diagnosis and assessment. Consensus statements

2004 · Gregory A. Grabowski, Generoso Andria, et al. · European Journal of Pediatrics · 137

Serum Chitotriosidase Activity Is Increased in Subjects With Atherosclerosis Disease

2003 · Marta Artieda, Ana Cenarro, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 127

PDF

Miglustat (NB-DNJ) works as a chaperone for mutated acid β-glucosidase in cells transfected with several Gaucher disease mutations

2005 · Pilar Alfonso, Sandra Pampín, et al. · Blood Cells Molecules and Diseases · 123

Tendon Xanthomas in Familial Hypercholesterolemia Are Associated With Cardiovascular Risk Independently of the Low-Density Lipoprotein Receptor Gene Mutation

2005 · Fernando Civeira, Sergio Castillo, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 122

PDF

Force Majeure: Therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher disease

2009 · Carla E.M. Hollak, Stephan vom Dahl, et al. · Blood Cells Molecules and Diseases · 95

Aragon workers’ health study – design and cohort description

2012 · José A Casasnovas, Victor Alcaide, et al. · BMC Cardiovascular Disorders · 90

PDF

Usefulness of Triglycerides-to–High-Density Lipoprotein Cholesterol Ratio for Predicting the First Coronary Event in Men

2009 · Alberto Cordero, Eva Andrés, et al. · The American Journal of Cardiology · 90

Frequency of Low-Density Lipoprotein Receptor Gene Mutations in Patients With a Clinical Diagnosis of Familial Combined Hyperlipidemia in a Clinical Setting

2008 · Fernando Civeira, Estibaliz Jarauta, et al. · Journal of the American College of Cardiology · 84

The Use of Achilles Tendon Sonography to Distinguish Familial Hypercholesterolemia from Other Genetic Dyslipidemias

2005 · Mireia Junyent, Rosa Gilabert, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 84

PDF

Molecular characterization of familial hypercholesterolemia in Spain: Identification of 39 novel and 77 recurrent mutations in LDLR

2004 · Pilar Mozas, Sergio Castillo, et al. · Human Mutation · 84

PDF

Report of the Spanish Gaucher's disease registry: clinical and genetic characteristics.

2000 · P Giraldo, M Pocoví, et al. · PubMed · 83

Neurological evaluation of patients with Gaucher disease diagnosed as type 1

2007 · J L Capablo, A Saenz de Cabezon, et al. · Journal of Neurology Neurosurgery & Psychiatry · 78

Apolipoprotein E gene mutations in subjects with mixed hyperlipidemia and a clinical diagnosis of familial combined hyperlipidemia

2012 · María Solanas-Barca, Isabel de Castro-Orós, et al. · Atherosclerosis · 74

Homozygous Familial Hypercholesterolemia in Spain

2016 · Rosa M. Sánchez-Hernández, Fernando Civeira, et al. · Circulation Cardiovascular Genetics · 72

Tendon xanthomas in familial hypercholesterolemia are associated with a differential inflammatory response of macrophages to oxidized LDL

2005 · Marta Artieda, Ana Cenarro, et al. · FEBS Letters · 72

PDF

Real-world clinical experience with long-term miglustat maintenance therapy in type 1 Gaucher disease: the ZAGAL project

2009 · P. Giraldo, P. Alfonso, et al. · Haematologica · 67

PDF

Neurologic Improvement in a Type 3 Gaucher Disease Patient Treated with Imiglucerase/Miglustat Combination

2007 · Jose L. Capablo, Rafael Franco, et al. · Epilepsia · 64

Works count: 281

Citation count: 6,112

H-index: 45

I10-index: 125